These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 35489960)
1. Differences in Mortality Among Infants With Neonatal Opioid Withdrawal Syndrome. Austin AE; Di Bona V; Cox ME; Proescholdbell SK; Naumann RB Am J Prev Med; 2022 Oct; 63(4):619-623. PubMed ID: 35489960 [TBL] [Abstract][Full Text] [Related]
2. Prenatal Use of Medication for Opioid Use Disorder and Other Prescription Opioids in Cases of Neonatal Opioid Withdrawal Syndrome: North Carolina Medicaid, 2016-2018. Austin AE; Bona VD; Cox ME; Proescholdbell S; Fliss MD; Naumann RB Am J Public Health; 2021 Sep; 111(9):1682-1685. PubMed ID: 34383554 [No Abstract] [Full Text] [Related]
3. Maternal Opioid Use Disorder and the Risk of Postneonatal Infant Mortality. Grossarth S; Osmundson SS; Wiese AD; Phillips SE; Pham A; Leech AA; Patrick SW; Spieker AJ; Grijalva CG; Adgent MA JAMA Pediatr; 2023 Jul; 177(7):675-683. PubMed ID: 37155175 [TBL] [Abstract][Full Text] [Related]
4. Long-term mortality in mothers of infants with neonatal abstinence syndrome: A population-based parallel-cohort study in England and Ontario, Canada. Guttmann A; Blackburn R; Amartey A; Zhou L; Wijlaars L; Saunders N; Harron K; Chiu M; Gilbert R PLoS Med; 2019 Nov; 16(11):e1002974. PubMed ID: 31770382 [TBL] [Abstract][Full Text] [Related]
6. Impact of maternal medication for opioid use disorder on neurodevelopmental outcomes of infants treated for neonatal opioid withdrawal syndrome. King RS; Peacock-Chambers E; Wilson D; Shimer J; Foss S; Visintainer P; Singh R J Neonatal Perinatal Med; 2021; 14(4):463-473. PubMed ID: 33843701 [TBL] [Abstract][Full Text] [Related]
7. Assessing the Impact of Prenatal Medication for Opioid Use Disorder on Discharge Home With Parents Among Infants With Neonatal Opioid Withdrawal Syndrome. Singleton R; Rutz S; Day G; Hammes M; Wilson AS; Herrick M; Mazut C; Brunner L; Prince J; Desnoyers C; Shaw J; Hirschfeld M; Palis H; Slaunwhite A J Addict Med; 2022 Nov-Dec 01; 16(6):e366-e373. PubMed ID: 35245916 [TBL] [Abstract][Full Text] [Related]
8. Delivery timing for the opioid-exposed infant. Sanusi A; Gray M; Xue Y; Mohr S; Curtis P; Dismukes J; Gentle S; Szychowski JM; Brocato B; Casey B; Harper L; Sinkey R Am J Obstet Gynecol MFM; 2022 Nov; 4(6):100719. PubMed ID: 35977700 [TBL] [Abstract][Full Text] [Related]
9. Association between pharmacologic treatment and hospital utilization at birth among neonatal opioid withdrawal syndrome mother-infant dyads. Hahn PD; Melvin P; Graham DA; Ozonoff A; Milliren CE J Perinatol; 2023 Mar; 43(3):283-292. PubMed ID: 36717607 [TBL] [Abstract][Full Text] [Related]
10. An epidemiological examination of neonatal opioid withdrawal syndrome and maternal and infant characteristics. Schwartz AN; Meschke LL Arch Womens Ment Health; 2024 Oct; 27(5):863-867. PubMed ID: 38573341 [TBL] [Abstract][Full Text] [Related]
11. Mental Health of Mothers of Infants with Neonatal Abstinence Syndrome and Prenatal Opioid Exposure. Faherty LJ; Matone M; Passarella M; Lorch S Matern Child Health J; 2018 Jun; 22(6):841-848. PubMed ID: 29417369 [TBL] [Abstract][Full Text] [Related]
12. Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero. Lawlor ML; Shook LA; McQuerry K; Srinivasan A; Johnson QB; Chavan NR; Critchfield AS J Matern Fetal Neonatal Med; 2020 Aug; 33(16):2718-2722. PubMed ID: 30563376 [No Abstract] [Full Text] [Related]
16. Can umbilical cord testing add to maternal urine drug screen for evaluation of infants at risk of neonatal opioid withdrawal syndrome? Gersch H; Shah D; Chroust A; Bailey B J Matern Fetal Neonatal Med; 2023 Dec; 36(1):2211706. PubMed ID: 37183045 [TBL] [Abstract][Full Text] [Related]
17. Are infants exposed to methadone in utero at an increased risk for mortality? Kelly LE; Rieder MJ; Bridgman-Acker K; Lauwers A; Madadi P; Koren G J Popul Ther Clin Pharmacol; 2012; 19(2):e160-5. PubMed ID: 22580362 [TBL] [Abstract][Full Text] [Related]
18. Prescription opioid epidemic and infant outcomes. Patrick SW; Dudley J; Martin PR; Harrell FE; Warren MD; Hartmann KE; Ely EW; Grijalva CG; Cooper WO Pediatrics; 2015 May; 135(5):842-50. PubMed ID: 25869370 [TBL] [Abstract][Full Text] [Related]
19. Hospital Outcomes of Infants with Neonatal Opioid Withdrawal Syndrome at a Tertiary Care Hospital with High Rates of Concurrent Nonopioid (Polysubstance) Exposure. Morris E; Bardsley T; Schulte K; Seidel J; Shakib JH; Buchi KF; Fung CM Am J Perinatol; 2022 Mar; 39(4):387-393. PubMed ID: 32892326 [TBL] [Abstract][Full Text] [Related]
20. One-Year Postpartum Mental Health Outcomes of Mothers of Infants with Neonatal Abstinence Syndrome. Corr TE; Schaefer EW; Hollenbeak CS; Leslie DL Matern Child Health J; 2020 Mar; 24(3):283-290. PubMed ID: 31925632 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]